Global /Taiwan /Healthcare /Drug Manufacturers - General /3205

Sagittarius Life Science Corp.

3205

• TPEX: 3205 • Delayed

56.20TWD -0.2%

1.79 USD

As of 6 June 2026, Sagittarius Life Science Corp. has a market cap of $120.89M USD, ranking #24221 globally and #1263 in Taiwan. It ranks #2170 in the Healthcare sector, and #785 in the Drug Manufacturers - General industry.

Global Rank

24221

Country Rank

1263

Sector Rank

2170

Industry Rank

785

Key Stats

Market Cap

$120.89MUSD

3.8B TWD

Enterprise Value

$95.44MUSD

3.0B TWD

Revenue (TTM)

$11.0MUSD

346.08M TWD

EBITDA (TTM)

-$1.69MUSD

-53.17M TWD

Net Income (TTM)

-$1.58MUSD

-49.56M TWD

EBITDA Margin

-15%

Profit Margin

-14%

PS Ratio

11.0

PB Ratio

3.6

Company Profile

Country (HQ)

Taiwan

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Junheng Chen open_in_new

Employees

112

Founded

1998

Website

naturalbiokey.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-0.2%	-2.9%	-0.4%	8.7%	8.5%	9.7%	142%	28%	89%

News

Markets

Exchange	Ticker	Price	Quotes
Taipei Exchange (TPEX) MIC: ROCO PRIMARY	3205 佰研生化科技股份有限公司 ISIN: TW0003205001 Shares Out.: Shares Outstanding: 67.546M¹ TV: TradingView: TPEX: 3205 SA: Stock Analysis: TPEX: 3205 YF: Yahoo Finance: 3205.TWO GF: Google Finance: TPEX: 3205 BA: Barron's: 3205 MS: Morningstar: ROCO: 3205	56.20 TWD	TV: TradingView: TPEX: 3205 SA: Stock Analysis: TPEX: 3205 YF: Yahoo Finance: 3205.TWO GF: Google Finance: TPEX: 3205 BA: Barron's: 3205 MS: Morningstar: ROCO: 3205

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Sagittarius Life Science Corp.

Sagittarius Life Science Corp engages in the research, development, and sale of Chinese and western medicines, and health food products in Taiwan and Asia. It also offers organic food, daily necessities, and pet food; and engages in the research and development of biotechnology. Sagittarius Life Science Corp was founded in 1998 and is based in Taipei, Taiwan.

Similar Companies

Industry: Drug Manufacturers - General (Taiwan)

Name	Market Cap (USD) diff.	PE	Country
PharmaEssentia Corp. TWSE: 6446	$7.8B 245.34B TWD 6K%	48.6	Taiwan
Lotus Pharmaceutical Co., Ltd. TWSE: 1795	$1.84B 57.95B TWD 1K%	12.2	Taiwan
Center Laboratories, Inc. TPEX: 4123	$925.55M 29.11B TWD 666%	3.4	Taiwan
Lumosa Therapeutics Co., Ltd. TPEX: 6535	$809.3M 25.46B TWD 569%	-	Taiwan
Oneness Biotech Co., Ltd. TPEX: 4743	$789.12M 24.82B TWD 553%	-	Taiwan
TTY Biopharm Company Ltd. TPEX: 4105	$584.14M 18.38B TWD 383%	11.8	Taiwan

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 630K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 453K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 298K%	97.4	United States
Roche Holding AG SIX: RO	$324.68B 256.25B CHF 268K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$289.43B 215.59B GBP 239K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$277.35B 218.9B CHF 229K%	20.5	Switzerland

chevron_leftBack